Studies and trials

Filter results

1-10 of 70 search results

AML LI-1

AML16 and LI-1 together have evaluated (or are in the process of evaluating) 11 novel therapies with more treatments due to come on board later in 2016.

AML15, AML16

In patients given intensive chemotherapy, AML16 for the first time demonstrated the value of measuring response using sophisticated laboratory techniques to identify patients who, although they might be in remission, will relapse early and are therefore candidates for novel treatments or intensification.

AML17

Between 2009 and 2014 AML17 recruited over 3,500 patients aged generally under 60 to what is the largest ever trial in Acute Myeloid Leukaemia run in the UK.

AML18

AML18 is an international trial looking to identify the best treatment for the third course of chemotherapy across 100 centres in the UK, Denmark and Australasia and is focused on older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome.

AML19

AML19 is the current trial for younger adults with acute myeloid leukaemia (AML) or high risk myelodysplastic syndrome (MDS).

ANDREA-LD

Community led ANti-psychotic Drug REduction for Adults with Learning Disabilities: A Randomised Double-blind Placebo Controlled Trial.

BATHE

A study to determine whether adding in a bath emollient is helpful in relieving childhood eczema.

Building Blocks

A randomised controlled trial (RCT) to evaluate the Family Nurse Partnership in England.

Building Blocks 2-6

Evaluating the long-term effectiveness, and the cost and consequences of the Family Nurse Partnership parenting support programme in reducing maltreatment in young children.

CEBOC

Evaluation of the safety of cediranib in the prevention of bowel perforation in platinum-resistant ovarian cancer.